
According to a report by Amar Ujala, the Food and Drug Administration (FDA) has taken a firm stance regarding the endorsement of products by prominent Indian celebrities. The FDA Commissioner has reportedly issued notices to several high-profile actors, including Shah Rukh Khan, Ajay Devgn, and Tiger Shroff, emphasizing that all individuals involved in the promotion of goods are held accountable for the claims made in advertisements.
The regulatory body has signaled a zero-tolerance approach toward misleading endorsements, asserting that celebrities cannot be exempt from responsibility when promoting products that may violate safety or advertising standards. This move is part of a broader effort by Indian authorities to ensure greater transparency and consumer protection in the advertising sector, particularly concerning health and lifestyle products.
While the actors have not yet issued a collective response, the FDA's actions highlight an increasing trend of regulatory scrutiny directed at the intersection of celebrity influence and consumer welfare. The Commissioner's remarks underscore a warning that the department intends to pursue accountability across the board, regardless of the stature of the individuals involved in the promotional campaigns.
The report originates from Amar Ujala, a credible regional news outlet in India, regarding ongoing regulatory actions by the Food and Drug Administration (FDA) against celebrities endorsing products. While the specific quotes and notices are consistent with the FDA's recent public stance on misleading advertisements, this specific instance of notices issued to these actors is a localized regulatory development.
No corroborating trusted sources found.
Original report: Amar Ujala